Contrast media injectors market seen reaching $2.73 billion by 2030

The Business Research Company says the contrast media injectors market will grow from $1.92 billion in 2026 to $2.73 billion by 2030, driven by more imaging procedures, automation and demand for non-invasive diagnostics. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Contrast media injectors are tied to CT, MRI and other diagnostic imaging workflows that depend on precise delivery of contrast agents. - The market’s projected 9.1% CAGR through 2030 points to steady demand for imaging infrastructure, automation and patient-safe diagnostic tools. - Non-invasive testing volumes are still rising, which supports more use of injector systems in clinical settings.

What happened: - The Business Research Company released its "Contrast Media Injectors Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035" on August 1, 2026. - The report says the market grew from $1.77 billion in 2025 to $1.92 billion in 2026. - The company projects the market will reach $2.73 billion by 2030. - The report gives that outlook a 9.1% CAGR. - North America held the leading market position in 2025. - Asia-Pacific is forecast to be the fastest-growing region over the coming years.

The details: - Historical growth was driven by more diagnostic imaging procedures, expansion of radiology departments, broader use of contrast-enhanced imaging and wider adoption of automated injection systems. - The report points to increased investment in advanced imaging infrastructure as a key support for future growth. - Other growth drivers include greater use of minimally invasive diagnostics, more outpatient imaging centers, workflow automation and tighter integration with imaging software. - The report highlights emerging trends including dual-head injector systems, syringeless injector technology, smart dose management software and MRI-compatible injectors. - The company also flags a stronger focus on patient safety and injection accuracy. - Contrast media injectors are medical devices that deliver contrast agents to improve tissue visibility during imaging procedures. - The Business Research Company says the devices help improve diagnostic outcomes and surgical results through higher accuracy and precision. - The report cites the UK National Health Service, which reported 11.4 million diagnostic tests potentially related to cancer diagnosis or exclusion in 2023-24, up 2.8% from 11.1 million in 2022-23. - The NHS also reported chest X-ray referrals up 1.4%, pelvic ultrasound volumes up 5.1% and kidney ultrasound volumes up 1.3%. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - The report offers a free sample here. - The full report is available here.

Between the lines: - The forecast suggests buyers are prioritizing tools that speed workflows without sacrificing dosing precision. - The shift toward MRI-compatible, syringeless and software-linked injectors suggests product differentiation is moving toward integration and safety rather than hardware alone. - The regional outlook implies mature demand in North America and faster expansion in markets still building imaging capacity.

What's next: - The report expects more growth as imaging centers expand and automation becomes more common. - Adoption of dual-head systems and smart dose software will likely shape product competition over the next several years. - The market will also track broader outpatient imaging growth and continuing demand for non-invasive diagnostics. - The report says the 2026 market outlook and forecast extend through 2035.